ZD0473: Phase I data; Phase II

In an ongoing U.S. trial of 11 patients with refractory advanced solid tumors, doses

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE